Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases
Authors:
- 1 May 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 22 (5) , 1198-1208
Abstract
Anemia coexists with inflammatory bowel disease (IBD) in up to two-thirds of patients, significantly impairing quality of life. The most common typesKeywords
This publication has 124 references indexed in Scilit:
- High-Throughput Screening of Small Molecules Identifies Hepcidin AntagonistsMolecular Pharmacology, 2013
- The bone morphogenetic protein–hepcidin axis as a therapeutic target in inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel diseaseBritish Journal of Nutrition, 2011
- Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in ratsBlood, 2011
- A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implicationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Clinical Use of Intravenous Iron: Administration, Efficacy, and SafetyHematology-American Society Hematology Education Program, 2010
- Individualized Treatment for Iron-deficiency Anemia in AdultsThe American Journal of Medicine, 2008
- Forging a field: the golden age of iron biologyBlood, 2008
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balanceJournal of Clinical Investigation, 2007
- Impaired intestinal iron absorption in Crohnʼs disease correlates with disease activity and markers of inflammationInflammatory Bowel Diseases, 2006